Trends in in-hospital outcomes among adults hospitalized with exacerbation of chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 6, 2015, Pages 636-642

  Lima, Fabio V ^a   Yen, Tzyy Yun Michael ^a   Patel, Jignesh K ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ARTIFICIAL VENTILATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; ICD-9; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; OUTCOME ASSESSMENT; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; ADULT; AGE; COHORT ANALYSIS; COMPLICATION; EPIDEMIOLOGY; HOSPITAL MORTALITY; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; UNITED STATES;

EID: 84951573767     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2015.1020151     Document Type: Article

References (31)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
2. National Heart, Lung, and Blood Institute. Data Fact Sheet: Chronic Obstructive Pulmonary Disease. Report no. 03-5229. Bethesda, MD: National Heart, Lung, and Blood Institute; 2003.
3. Minino AM, Xu JQ, Kochanek K. Deaths: preliminary data for 2008. Natl Vital Stat Rep 2010; 59: 7.
4. National Heart Lung and Blood Institute. Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Heart, Lung, and Blood Institute, 2009.
5. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007; 370: 786-795.
6. Snow V, Lascher S, Mottur-Pilson C. Joint expert panel on chronic obstructive pulmonary disease of the American College of Chest Physicians and the American College of Physicians-American Society of Internal Medicine. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 2001; 134: 595-599.
7. McGarvey LP, Matthias J, Anderson JA, et al. Ascertainment of cause-specific mortality in COPD: operations of the torch clinical endpoint committee. Thorax 2007; 62: 411-415.
8. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructvie pulmonary disease. N Engl J Med 2007; 356: 775-789.
9. Lee TA, Wilke C, Joo M, et al. Outcomes associated with tiotropium. Arch Intern Med 2009; 169: 1403-1411.
10. Tashkin DP, Celli B, Senn S, et al. The 4-year trial of tiotropiumin chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-1554.
11. Calverley PM, Rennard SI. What have we learned from large drug treatment trials in COPD? Lancet 2007; 370: 774-785.
12. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011 Aug 2; 155 (3): 179-91.
13. Mannino DA, Buist SA. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-773.
14. Baillargeon J, Wang Y, Kuo YF, et al. Temporal trends in hospitalization rates for older adults with chronic obstructive pulmonary disease. Am J Med 2013; 126 (7): 607-614.
15. Soriano JB, Ancochea J, Miravitlles M, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997-2007. Eur Respir J 2010; 36: 758-765.
16. Gershon AS, Wang C, Wilton AS, et al. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: A Population Based Study. Arch Intern Med 2010; 170 (6): 560-565.
17. Simpson CR, Hippisley J, Sheikh A. Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51,804 patients. Br J Gene Pract 2010; e277-e284.
18. Tan WC. Trends in chronic obstructive pulmonary disease in the Asia-Pacific regions. Curr Opin Pulm Med 2011; 17: 56-61.
19. Ekstrom MP, Wagner P, Strom KE. Trends in Cause-Specific Mortality in Oxygen-dependent Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2011; 183: 1032-1036.
20. de Miguel-Diaz J, Jimenez-Garcia R, Hernandez-Barrera V, et al. Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med 2013; 107: 717-723.
21. Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012; 67: 957-963.
22. Ford ES. Hospital discharges, readmissions, and emergency department visits for chronic obstructive pulmonary disease or bronchiectasis among U.S. adults: findings from the Nationwide Inpatient Sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011. Chest 2014. [epub ahead of print].
23. Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. New Eng J Med 2013; 368 (4): 351-364.
24. Ram FS, Picot J, Lightowler J, Wedzicha JA. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004; 3: CD004104.
25. Stefan MS, Shieh MS, Pekow PS, et al. Trends in mechanical ventilation among patients hospitalized with acute exacerbation of COPD in the United States, 2001 to 2011. Chest 2014. [epub ahead of print].
26. Taga S, Taniguchi H, Watanabe N, et al. Predictors of the need to initiate noninvasive ventilation in stable oupatients with acute exacerbation of chronic obstructive pulmonary disease. Intern Med 2013; 52: 1781-1786.
27. Dalal AA, Liu F, Riedel AA. Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009. Int J Chron Obstruct Pulmon Dis 2011; 6: 533-542.
28. Dalal AA, Christensen L, Liu F, Riedel AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis 2010; 5: 341-349.
29. Dalal AA, Shah M, D'Souza AO, Rane P. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med 2011; 105 (3): 454-460.
30. Cruz J, Brooks D, Marques A. Home telemonitoring effectiveness in COPD: a systematic review. Int J Clin Pract 2014; 68 (3): 368-378.
31. Stein BD, Bautista A, Schumock GT, et al. The validity of ICD-9-CM diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest 2012; 141: 87-93.